Stockreport

BioVaxys Acquires All Intellectual Property, Immunotherapeutics Platform Technology, and Clinical Stage Assets of the Former IMV Inc.

Horizon Technology Finance Corporation  (HRZN) 
Last horizon technology finance corporation earnings: 4/28 04:15 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.horizontechfinance.com/investor-relations
PDF VANCOUVER, BC, Feb. 12, 2024 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys" or "Company") announced that it has executed the [Read more]